Search Results - "Jett, J."

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer by Bonomi, P.D., Gandara, D., Hirsch, F.R., Kerr, K.M., Obasaju, C., Paz-Ares, L., Bellomo, C., Bradley, J.D., Bunn Jr, P.A., Culligan, M., Jett, J.R., Kim, E.S., Langer, C.J., Natale, R.B., Novello, S., Pérol, M., Ramalingam, S.S., Reck, M., Reynolds, C.H., Smit, E.F., Socinski, M.A., Spigel, D.R., Vansteenkiste, J.F., Wakelee, H., Thatcher, N.

“…Upregulated expression and aberrant activation of the epidermal growth-factor receptor (EGFR) are found in lung cancer, making EGFR a relevant target for…”
Get full text

A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study by Dy, G. K., Miller, A. A., Mandrekar, S. J., Aubry, M.-C., Langdon, R. M., Morton, R. F., Schild, S. E., Jett, J. R., Adjei, A. A.

“…Background: The aim of the present study was to evaluate the clinical activity of imatinib mesylate in patients with recurrent and refractory c-kit-expressing…”
Get full text

Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum by Strollo, D C, Rosado-de-Christenson, M L, Jett, J R

“…Lymphoma, mediastinal cysts, and neurogenic neoplasms are the most common primary middle and posterior mediastinal tumors. Lymphoma may involve the anterior,…”
Get more information

P.3.d.018 Phase 2 clinical trial of TC-5619, an alpha 7 nicotinic receptor agonist in the treatment of negative and cognitive symptoms in schizophrenia by Hosford, D, Dvergsten, C, Beaver, J, Segreti, A.C, Toler, S, Farr, M.G, Joseph, M, Jett, J, Lippiello, P, Bencherif, M

Get full text

Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum by Strollo, D C, Rosado de Christenson, M L, Jett, J R

“…Primary anterior mediastinal neoplasms comprise a diverse group of tumors and account for 50% of all mediastinal masses. Thymomas are most common and can be…”
Get more information

The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study by Kishi, K, Gurney, J.W, Schroeder, D.R, Scanlon, P.D, Swensen, S.J, Jett, J.R

“…A matched case-controlled study was conducted to determine if airway obstruction or emphysema were associated with an increased risk of lung cancer. Lung…”
Get full text

Superior Pulmonary Sulcus Tumors and Pancoast's Syndrome by Arcasoy, Selim M, Jett, James R

“…Pancoast's syndrome is a constellation of characteristic symptoms and signs that includes shoulder and arm pain along the distribution of the eighth cervical…”
Get full text

Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy by SCHILLER, Joan H, ADAK, Sudeshna, KOHMAN, Leslie, JOHNSON, David H, FEINS, Richard H, KELLER, Steven M, FRY, Willard A, LIVINGSTON, Robert B, HAMMOND, M. Elizabeth M, WOLF, Barbara, SABATINI, Linda, JETT, James

“…To determine the prognostic and predictive significance of p53 and K-ras mutations in patients with completely resected non-small-cell lung cancer (NSCLC)…”
Get full text

Spiral computed tomography screening for lung cancer is ready for prime time by Jett, J R

Get full text

Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma by BONNER, J. A, SLOAN, J. A, TAZELAAR, H. D, HILLMAN, S, JETT, J. R, SHANAHAN, T. G, BROOKS, B. J, MARKS, R. S, KROOK, J. E, GERSTNER, J. B, MAKSYMIUK, A, LEVITT, R, MAILLIARD, J. A

“…Because small-cell lung cancer is a rapidly proliferating tumor, it was hypothesized that it may be more responsive to thoracic irradiation (TI) given…”
Get full text

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary by Travis, William D, Brambilla, Elisabeth, Noguchi, Masayuki, Nicholson, Andrew G, Geisinger, Kim, Yatabe, Yasushi, Powell, Charles A, Beer, David, Riely, Greg, Garg, Kavita, Austin, John H M, Rusch, Valerie W, Hirsch, Fred R, Jett, James, Yang, Pan-Chyr, Gould, Michael

“…The American Thoracic Society is a cosponsor of a newly published lung adenocarcinoma classification. An international multidisciplinary panel of experts was…”
Get full text

Erdheim-Chester disease: Clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease by EGAN, A. J. M, BOARDMAN, L. A, TAZELAAR, H. D, SWENSEN, S. J, JETT, J. R, YOUSEM, S. A, MYERS, J. L

“…Erdheim-Chester disease is a clinicopathologic entity defined by a characteristic pattern of symmetric osteosclerosis caused by an infiltrate of mononuclear…”
Get full text

Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer by Ramalingam, S., Belani, C. P., Day, R., Zamboni, B. A., Jacobs, S. A., Jett, J. R.

“…Background: This phase II study was conducted to evaluate the safety and efficacy of the combination of paclitaxel and topotecan for patients with extensive…”
Get full text

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study by Rowland, Jr, K M, Loprinzi, C L, Shaw, E G, Maksymiuk, A W, Kuross, S A, Jung, S H, Kugler, J W, Tschetter, L K, Ghosh, C, Schaefer, P L, Owen, D, Washburn, Jr, J H, Webb, T A, Mailliard, J A, Jett, J R

“…Megestrol acetate has been reported to improve appetite and quality of life and to decrease nausea and vomiting in patients with cancer anorexia/cachexia. The…”
Get more information

Characteristics of Different Nucleic Acid Staining Dyes for DNA Fragment Sizing by Flow Cytometry by Yan, Xiaomei, Grace, W. Kevin, Yoshida, Thomas M, Habbersett, Robert C, Velappan, Nileena, Jett, James H, Keller, Richard A, Marrone, Babetta L

“…An efficient and reliable double-stranded DNA (dsDNA) staining protocol for DNA fragment sizing by flow cytometry is presented. The protocol employs 0.8 μΜ of…”
Get full text

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer by TRIVERS, G. E, DE BENEDETTI, V. M. G, MILLER, R. D, HARRIS, C. C, CAWLEY, H. L, CARON, G, HARRINGTON, A. M, BENNETT, W. P, JETT, J. R, COLBY, T. V, TAZELAAR, H, PAIROLERO, P

“…Serum anti-p53 antibodies (p53-Abs) may be surrogate markers for both p53 alterations and preclinical cancer. Ancillary to a prospective trial to abate…”
Get full text

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression by Guinee, Jr, D G, Travis, W D, Trivers, G E, De Benedetti, V M, Cawley, H, Welsh, J A, Bennett, W P, Jett, J, Colby, T V, Tazelaar, H

“…Little is known about the molecular mechanisms of lung carcinogenesis in women. We initiated an investigation of the role of gender in pulmonary carcinogenesis…”
Get more information

A phase III randomized, double-blind, placebo-controlled trial of the epidermal growth factor receptor inhibitor gefitinb in completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): NCIC CTG BR.19 by Goss, G. D., Lorimer, I., Tsao, M. S., O'Callaghan, C. J., Ding, K., Masters, G. A., Roberts, P., Jett, J. R., Edelman, M. J., Shepherd, F. A.

“…Abstract only LBA7005 Background: In meta-analyses, platinum-based adjuvant (adj) chemotherapy (CT) in completely resected NSCLC increased cure rate by ∼5%. At…”
Get full text

Rapid sizing of individual fluorescently stained DNA fragments by flow cytometry by Goodwin, Peter M., Johnson, Mitchell E., Martin, John C., Ambrose, W.Patrick, Marrone, Babetta L., Jett, James H., Keller, Richard A.

“…Large, fluorescently stained restriction fragments of lambda phage DNA are sized by passing Individual fragments through a focused continuous wave laser beam…”
Get full text

Current treatment of unresectable lung cancer by Jett, J R

“…The treatment of choice for most cases of non-small-cell lung cancer is surgical resection; however, which patients with stage IIIA disease are surgical…”
Get more information